Concepedia

Amit Manhas

AM

Statistics

Publications

12

Citations

503

H-Index

12

Active since

2003

Affiliations

Central Drug Research Institute(Current)

Cardiovascular Institute of the South

Stanford University

Academy of Scientific and Innovative Research

Stanford Medicine

Amit Manhas is an author at Central Drug Research Institute specializing in pharmacology, medicine, and cardiology.

ORCID

Publications per year

2003–2024

12

Publications

12

Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation

Tzu-Tang Wei, Mark Chandy, Masataka Nishiga et al. · Cell · 2022 · 129 citations · Full text

, , +12

Inhibition of fatty acid synthase is protective in pulmonary hypertension

Neetu Singh, Amit Manhas, Gurpreet Kaur et al. · British Journal of Pharmacology · 2016 · 69 citations · Full text

, , +15

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common<i>ALDH2</i>alcohol flushing variant

Hongchao Guo, Xuan Yu, Yu Liu et al. · Science Translational Medicine · 2023 · 51 citations · Full text

, , +17

Danaparoid for heparin‐induced thrombocytopenia: an analysis of treatment failures

Sandeep Kodityal, Amit Manhas, Mark M. Udden et al. · European Journal Of Haematology · 2003 · 44 citations

, , +17

CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity

Mengcheng Shen, Yanxia Liu, Amit Manhas et al. · Cell stem cell · 2024 · 39 citations · Full text

, , +16

1–5 of 12